Tempus AI (TEM) is soaring 13% today after investment bank TD Cowen reinstated coverage of the shares with a Buy rating. TEM ...

Anyone who’s looked at the market in the last couple of weeks will know that there were some events that shook investors.

We came across a bullish thesis on Tempus AI, Inc. (TEM) on Substack by Market Moves by GBC. In this article, we will ...

As disruption remains the name of the game in the artificial intelligence (AI) world, any conversation not involving Cathie Wood would remain incomplete. Known for making outsized bets on disruptive ...

Tempus AI’s moat on its healthcare diagnostics platform is being built around three main product lines, although revenue is mainly being driven by Genomics and Data. Diagnostic testing and ...

Tempus AI (NASDAQ: TEM), a healthcare technology company, saw its stock surge 45% in a week after the company announced the launch of its AI app – Olivia. TEM stock was listed on June 14 ...

The healthcare industry is undergoing rapid transformation, driven by advancements in technology, artificial intelligence, and data analytics. Companies at the forefront of this shift are ...

Tempus AI is well-placed to benefit from the rise of precision medicine and AI in health care. Its over 20 petabytes of data create a moat that will be difficult for others to replicate.